Carboplatin-etoposide chemotherapy (CB-ET) for patients diagnosed with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): findings from a European Neuroendocrine Tumor Society Centre of Excellence.
dc.contributor.author | Frizziero, Melissa | |
dc.contributor.author | Lamarca, Angela | |
dc.contributor.author | Kordatou, Zoe | |
dc.contributor.author | Barriuso, Jorge | |
dc.contributor.author | Nuttall, Christina | |
dc.contributor.author | McNamara, Mairéad G | |
dc.contributor.author | Hubner, Richard A | |
dc.contributor.author | Mansoor, Was | |
dc.contributor.author | Manoharan, Prakash | |
dc.contributor.author | Valle, Juan W | |
dc.date.accessioned | 2018-05-15T20:18:45Z | |
dc.date.available | 2018-05-15T20:18:45Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Carboplatin-etoposide chemotherapy (CB-ET) for patients diagnosed with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): findings from a European Neuroendocrine Tumor Society Centre of Excellence. 2018, 106: 77-77 Neuroendocrinology | en |
dc.identifier.uri | http://hdl.handle.net/10541/621019 | |
dc.language.iso | en | en |
dc.title | Carboplatin-etoposide chemotherapy (CB-ET) for patients diagnosed with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): findings from a European Neuroendocrine Tumor Society Centre of Excellence. | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | The Christie NHS Foundation Trust, Manchester | en |
dc.identifier.journal | Neuroendocrinology | en |